A panel of advisers to the US Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose.
US FDA advisers vote in favor of booster for J&J COVID-19 vaccine
By REUTERS
11/25/2024 03:55 AM
By REUTERS
11/25/2024 01:29 AM
By REUTERS
11/24/2024 09:11 PM
By REUTERS
11/24/2024 06:51 PM
By REUTERS
11/24/2024 05:13 PM
By REUTERS
11/24/2024 03:21 PM
By REUTERS
11/24/2024 01:09 PM